The Feed

I have been following the cannabis sector since early 2013, and the stocks are very volatile to say the least. When I started following it, adult-use cannabis sales were legal nowhere. Now, about half of states in the U.S. have adult-use sales, and Canada has had legal adult-use cannabis since 2018. When I started following cannabis, its current medical cannabis program had not yet started, as Marihuana for Medical Purposes Regulations (MMPR) started in 2014 and was replaced

I saw a press release the other day that caught my attention. It was released by Protext Mobility (TXTM), and it was very bullish-sounding. The press release, published on 11/19, was a shareholder update . I don't follow TXTM closely. I did pay attention to its predecessor, Plandai Biotechnology, which was PLPL, but it was a total scam that I called out in 2013: It was $0.53 when I published and is now trading near zero. The relationship between PLPL and TXTM was explained i

When I wrote about MSOS here on 10/19, I explained why it was plunging . It had closed at $4.76 on 10/17, and today it closed at $3.16, down 33.6%. MSOS is now down 17.1% in 2025 after collapsing last year. The New Cannabis Ventures Global Cannabis Stock Index, which closed today at 5.91, is down 14.1%, which is down less than MSOS. Why MSOS Is Crashing MSOS started running up when Q3 began. Looking at it since 6/30, it has increased a lot, even after the sharp pullback recen

The cannabis industry has lost a lot of cannabis analysts during this bear market that started in early 2021. One of the analysts, formerly at Cantor Fitzgerald, runs his own firm now, Zuanic & Associates . I have not communicated with Pablo Zuanic directly since he started his new firm, perhaps never. I am not negative on him and do follow his work, citing it here and at Seeking Alpha at times. I am not writing this to criticize him or his work, but I do want to share that Z

Glass House Brands (GLASF) closed last night at $7.25. This is a lot higher than where it was when I explained in July why I don't like it after it had plunged following the ICE raid, but it is down from when I discussed its Q2 here in mid-August. I concluded in that piece that it was too expensive. Well, the company reports this evening after the close, and I still don't like it. The Glass House Brands Chart GLASF has rallied by 25% from its year-end close of $5.80. This g

I introduced this company on this blog in May, when it was known as Agrify, calling it a horrible stock . I don't always get my stock calls right, and often the timing is poor, and the stock then was $24.01. Now it is $31.00. The good news for you is that if you held this stock then, it is higher now. The good news for me is that I wrote it up in Seeking Alpha on September 9th, when the stock was near $40,, warning readers to avoid RYTHM (RYM) . Here is the summary from that

I shared a piece in mid-August warning investors about cannabis stock Leef Brands (LEEEF). The company reported its Q3 today, and it is already bad and about to get worse in my view. On 8/18, LEEEF closed at $0.2347, and today, before its report came out after the close, it closed at $0.2105. This is a decline of 10.3%. In the piece, I had pointed out ow it was up so much less than MSOS, which is an ETF that I think is horribly run. LEEEF is down now in 2025, but MSOS is up

On September 1, Labor Day, I posted that MSOS could plunge. While it did move up from that $5.57 level on 8/29, the end of August, it is now 4.76, down 14.5%. In August, it rallied 96.8%. Even after the retreat, it is up 24.9% year-to-date. This is much better than the overall cannabis sector as measured by the New Cannabis Ventures Global Cannabis Stock Index, which has gained 5.1% so far in 2025. It has declined a lot less than MSOS since the end of August, down just 6.6%.

I have been following the cannabis sector since 2013, when I launched 420 Investor in August of that year. It has had its ups and its...

I haven't written about any walks since May 26th, but I have been on many walks. My trip to the emergency room less than two weeks later...

When Barbara Simon passed away, her daughter, Rachel Simon, a long-time friend of mine, gave me a book that her parents had owned, The...